The fibrin-derived γ377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Perivascular microglia activation is a hallmark of inflammatory demyelination in multiple sclerosis (MS), but the mechanisms underlying microglia activation and specific strategies to attenuate their activation remain elusive. Here, we identify fibrinogen as a novel regulator of microglia activation and show that targeting of the interaction of fibrinogen with the microglia integrin receptor Mac-1 (alpha(M)beta(2), CD11b/CD18) is sufficient to suppress experimental autoimmune encephalomyelitis in mice that retain full coagulation function. We show that fibrinogen, which is deposited perivascularly in MS plaques, signals through Mac-1 and induces the differentiation of microglia to phagocytes via activation of Akt and Rho. Genetic disruption of fibrinogen-Mac-1 interaction in fibrinogen-gamma(390-396A) knock-in mice or pharmacologically impeding fibrinogen-Mac-1 interaction through intranasal delivery of a fibrinogen-derived inhibitory peptide (gamma(377-395)) attenuates microglia activation and suppresses relapsing paralysis. Because blocking fibrinogen-Mac-1 interactions affects the proinflammatory but not the procoagulant properties of fibrinogen, targeting the gamma(377-395) fibrinogen epitope could represent a potential therapeutic strategy for MS and other neuroinflammatory diseases associated with blood-brain barrier disruption and microglia activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4. Fibγ390-396A mice have reduced clinical scores and microglia activation in EAE. (A) Clinical scores of MOG35-55–immunized mice. Fibγ390-396A mice (blue triangles; n = 29) show statistically significant lower clinical scores (*, P < 0.01) than FibγWT control mice (black squares; n = 28). (B) Individual clinical scores from Fibγ390-396A and FibγWT mice on days 20 (average clinical score, 3.3 ± 0.22 for FibγWT [n = 19] vs. 2.1 ± 0.32 for Fibγ390-396A [n = 20]; P < 0.01) and 31 after immunization (average clinical score, 2.8 ± 0.25 for FibγWT [n = 15] vs. 1.5 ± 0.23 for Fibγ390-396A [n = 20]; P < 0.001). (C) Histological analysis of spinal cord sections stained with hematoxylin/eosin revealed increased inflammation in the FibγWT mice versus the Fibγ390-396A mice. (D) Survival curve of Fibγ390-396A and FibγWT mice after MOG35-55 immunization. Fibγ390-396A had a greater survival rate than the FibγWT mice. (E) Rotarod analysis of Fibγ390-396A and FibγWT mice on day 13. Fibγ390-396A significantly outperformed their wild-type counterparts in a behavioral test designed to assess motor skill function. n = 7 mice per group. **, P < 0.05. (F) Increased activation of IsoB4+ cells in FibγWT mice as compared with Fibγ390-396A mice. Bar, 58 μm. Data are represented as the mean clinical score and are mean ± SEM.](https://figures.cochat.ai/paper-figures/a0547757dbd947b08e158d353bae9525/the-fibrin-derived-377-395-peptide-inhibits-microglia-activation-and-suppresses-figure-4.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fggγ390–396A knock-in mice, which express fully coagulable fibrinogen that selectively lacks the CD11b receptor binding site (Adams et al., 2007; Flick et al., 2004).”
From Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an Alzheimer's disease model (2019) · cites this paper as Adams et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×
“Moreover, in vivo live imaging showed that BBB disruption provokes the immediate and focal activation of microglia (7).”
BackgroundNew Perspectives in Cell Adhesion: RGD and Integrins
Ruoslahti, E., & Pierschbacher, M. D. (1987) · Science · doi:10.1126/science.2821619 · Cited by 4,865
RGD AND OTHER RECOGNITION SEQUENCES FOR INTEGRINS
Ruoslahti, E. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.697 · Cited by 3,191 · cited 1×
“For peptide- recognizing integrin receptors, such as the RGD-recognizing αvβ3 and α5β1 integrins, both the peptide itself and antibodies against the peptide may inhibit integrin-mediated biological eff ects (49-52).”
BackgroundInflammatory Blockade Restores Adult Hippocampal Neurogenesis
Monje, M. L., Toda, H., & Palmer, T. D. (2003) · Science · doi:10.1126/science.1088417 · Cited by 2,426
Isaacson, P. G., Dogan, A., Price, S. K., & Spencer, J. (1989) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198912000-00004 · Cited by 1,915
Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669
Youssef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,097
Lehnardt, S., Massillon, L., Follett, P., Jensen, F. E., Ratan, R., Rosenberg, P. A., Volpe, J. J., & Vartanian, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432609100 · Cited by 1,052
Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases
Caron, E., & Hall, A. (1998) · Science · doi:10.1126/science.282.5394.1717 · Cited by 1,019
Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis
Greter, M., Heppner, F. L., Lemos, M. P., Odermatt, B. M., Goebels, N., Laufer, T., Noelle, R. J., & Becher, B. (2005) · Nature Medicine · doi:10.1038/nm1197 · Cited by 862 · cited 1×
“The CD11c+ perivascular dendritic cells are responsible for the presentation of myelin antigens (58, 59).”
Background
Cited by
Items 101–200 of 344
Blockade of Glutamine Synthetase Enhances Inflammatory Response in Microglial Cells
Palmieri, E. M., Menga, A., Lebrun, A., Hooper, D. C., Butterfield, D. A., Mazzone, M., & Castegna, A. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6715 · Cited by 74
Merson, T. D., Binder, M. D., & Kilpatrick, T. J. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8112-z · Cited by 84
Takagi, H., Arimura, K., Uto, T., Fukaya, T., Nakamura, T., Choijookhuu, N., Hishikawa, Y., & Sato, K. (2016) · Scientific Reports · doi:10.1038/srep24477 · Cited by 81
Models of multiple sclerosis: new insights into pathophysiology and repair
Lassmann, H. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282fee94a · Cited by 81
Self-citationGlutamine Synthetase: Localization Dictates Outcome
Castegna, A., & Menga, A. (2018) · Genes · doi:10.3390/genes9020108 · Cited by 82
Breaking boundaries—coagulation and fibrinolysis at the neurovascular interface
Bardehle, S., Rafalski, V. A., & Akassoglou, K. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00354 · Cited by 76
Self-citationAutoimmune and inflammatory mechanisms of CNS damage
Kapadia, M., & Šakić, B. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.008 · Cited by 82
Mechanisms of inflammation induced tissue injury in multiple sclerosis
Lassmann, H. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.04.003 · Cited by 86
Self-citationGalvão, R. P., & Zong, H. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-012-0006-3 · Cited by 80
Pinteaux‐Jones, F., Sevastou, I. G., Fry, V. A. H., Heales, S., Baker, D., & Pocock, J. M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05426.x · Cited by 70
Sharp, K., Dickson, A. R., Marchenko, S. A., Yee, K. M., Emery, P. N., Laidmäe, I., Uibo, R., Sawyer, E. S., Steward, O., & Flanagan, L. A. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.02.016 · Cited by 78
The effects of blood–brain barrier disruption on glial cell function in multiple sclerosis
McQuaid, S., Cunnea, P., McMahon, J., & Fitzgerald, U. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370329 · Cited by 69
Neuroinflammation: Microglial Activation During Sepsis
Michels, M., Danielski, L., Dal-Pizzol, F., & Petronilho, F. (2014) · Current Neurovascular Research · doi:10.2174/1567202611666140520122744 · Cited by 69
Muradashvili, N., Benton, R. L., Saatman, K. E., Tyagi, S. C., & Lominadze, D. G. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9550-3 · Cited by 69
Spatiotemporal distribution of fibrinogen in marmoset and human inflammatory demyelination
Lee, N. J., Ha, S.-K., Sati, P., Absinta, M., Luciano, N. J., Lefeuvre, J. A., Schindler, M. K., Leibovitch, E. C., Ryu, J. K., Petersen, M. A., et al. (2018) · Brain · doi:10.1093/brain/awy082 · Cited by 65
Self-citationCharacterization of a Novel Rat Model of Penetrating Traumatic Brain Injury
Plantman, S., Ng, K. C., Jia, L., Davidsson, J., & Risling, M. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2011.2182 · Cited by 68
In vivo spatiotemporal dynamics of NG2 glia activity caused by neural electrode implantation
Wellman, S. M., & Kozai, T. D. Y. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.037 · Cited by 73
Ma, S.-X., Seo, B. A., Kim, D., Xiong, Y., Kwon, S., Brahmachari, S., Kim, S., Kam, T., Nirujogi, R. S., Kwon, S. H., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c01002 · Cited by 66
Lynch, M. A. (2014) · Immunology · doi:10.1111/imm.12156 · Cited by 60
Winkler, A., Wrzos, C., Haberl, M., Weil, M., Gao, M., Möbius, W., Odoardi, F., Thal, D., Chang, M., Opdenakker, G., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci141694 · Cited by 50
Fibrinogen and Neuroinflammation During Traumatic Brain Injury
Sulimai, N., & Lominadze, D. G. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02012-2 · Cited by 64
Pesticides, Microglial NOX2, and Parkinson's Disease
Taetzsch, T., & Block, M. L. (2013) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21464 · Cited by 63
Mendiola, A. S., Garza, R., Cardona, S. M., Mythen, S. A., Lira, S. A., Akassoglou, K., & Cardona, A. E. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00303 · Cited by 56
Self-citationCoagulation Pathways in Neurological Diseases: Multiple Sclerosis
Ziliotto, N., Bernardi, F., Jakimovski, D., & Zivadinov, R. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00409 · Cited by 52
Metformin as a Potential Agent in the Treatment of Multiple Sclerosis
Dziedzic, A., Saluk, J., Miller, E. D., & Bijak, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175957 · Cited by 65
Hemostatic factors, innate immunity and malignancy
Degen, J. L., & Palumbo, J. S. (2012) · Thrombosis Research · doi:10.1016/s0049-3848(12)70143-3 · Cited by 62
Self-citationGöbel, K., Asaridou, C.-M., Merker, M., Eichler, S., Herrmann, A. M., Geuß, E., Ruck, T., Schüngel, L., Groeneweg, L., Narayanan, V., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810020116 · Cited by 58
Tumor Immune Microenvironment of Brain Metastases: Toward Unlocking Antitumor Immunity
Strickland, M. R., Alvarez-Breckenridge, C. A., Gainor, J. F., & Brastianos, P. K. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0976 · Cited by 59
Platelets and neurovascular inflammation
Chavakis, T., & Langer, H. F. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-02-0096 · Cited by 57
Dean, T., Mendiola, A., Yan, Z., Meza-Acevedo, R., Cabriga, B. S., Akassoglou, K., & Ryu, J. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03092-w · Cited by 49
Self-citationImmune response by microglia in the spinal cord
Olson, J. K. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05536.x · Cited by 60
Park-Min, K.-H., Lee, E. Y., Moskowitz, N. K., Lim, E., Lee, S.-K., Lorenzo, J. A., Huang, C., Melnick, A. M., Purdue, P. E., Goldring, S. R., et al. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1739 · Cited by 53
Hansmann, F., Herder, V., Kalkuhl, A., Haist, V., Zhang, N., Schaudien, D., Deschl, U., Baumgärtner, W., & Ulrich, R. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0942-3 · Cited by 59
Glat, M., Skaat, H., Menkes-Caspi, N., Margel, S., & Stern, E. A. (2013) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-11-32 · Cited by 53
Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry
Teunissen, C. E., Simmelink, M. J. A., Pham, T., Knol, J. C., Khalil, M., Trentini, A., Killestein, J., Nielsen, J., Vrenken, H., Popescu, V., et al. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511399614 · Cited by 56
Inflammation: major denominator of obesity, Type 2 diabetes and Alzheimer’s disease-like pathology?
Kacířová, M., Zmeškalová, A., Kořínková, L., Železná, B., Kuneš, J., & Maletínská, L. (2020) · Clinical Science · doi:10.1042/cs20191313 · Cited by 53
Binding of Efb from Staphylococcus aureus to Fibrinogen Blocks Neutrophil Adherence
Ko, Y.-P., Liang, X., Smith, C. W., Degen, J. L., & Höök, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.199687 · Cited by 56
Self-citationMukherjee, S., Chopra, A., Karmakar, S., & Bhat, G. S. (2024) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2024.2339260 · Cited by 56
Morgan, B. P., Gommerman, J. L., & Ramaglia, V. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.600656 · Cited by 59
Seyedsadr, M. S., Weinmann, O., Amorim, A., Ineichen, B. V., Egger, M., Mirnajafi-Zadeh, J., Becher, B., Javan, M., & Schwab, M. E. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.11.018 · Cited by 51
Yao, F., Luo, Y., Liu, Y.-C., Chen, Y., Li, Y.-T., Hu, X., You, X., Yu, S., Li, Z., Chen, L., et al. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-022-00223-9 · Cited by 52
Cole, H., Ohba, T., Nyman, J. S., Haro, H., Cates, J., Flick, M. J., Degen, J. L., & Schoenecker, J. G. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38639 · Cited by 55
Self-citationUibo, R., Laidmäe, I., Sawyer, E. S., Flanagan, L. A., Georges, P. C., Winer-Jones, J. P., & Janmey, P. A. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.01.007 · Cited by 52
Contribution of Fibrinogen to Inflammation and Neuronal Density in Human Traumatic Brain Injury
Jenkins, D., Craner, M. J., Esiri, M. M., & DeLuca, G. C. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2017.5291 · Cited by 53
EAAT expression by macrophages and microglia: still more questions than answers
Gras, G., Samah, B., Hubert, A., Léone, C., Porcheray, F., & Rimaniol, A. (2011) · Amino Acids · doi:10.1007/s00726-011-0866-6 · Cited by 49
Evaluation of fibrinogen self‐assembly: role of its αC region
Koo, J., Rafailovich, M. H., Medved, L. V., Tsurupa, G., Kudryk, B. J., LIU, Y., & Galanakis, D. K. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04072.x · Cited by 48
Plasmin-mediated fibrinolysis enables macrophage migration in a murine model of inflammation
Silva, L. M., Lum, A. G., Tran, C. L., Shaw, M. W., Gao, Z., Flick, M. J., Moutsopoulos, N. M., Bugge, T. H., & Mullins, E. S. (2019) · Blood · doi:10.1182/blood.2018874859 · Cited by 48
Self-citationImportance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination
Watzlawik, J. O., Warrington, A. E., & Rodriguez, M. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.13 · Cited by 53
Alruwaili, M., Al-Kuraishy, H. M., Alexiou, A. T., Papadakis, M., Alrashdi, B. M., Elhussieny, O., Saad, H. M., & Batiha, G. E. (2023) · Neurochemical Research · doi:10.1007/s11064-023-03981-1 · Cited by 45
Cajamarca, S. A., Norris, E. H., van der Weerd, L., Strickland, S., & Ahn, H. J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921327117 · Cited by 47
Microglia as therapeutic targets after neurological injury: strategy for cell therapy
Scott, M. C., Bedi, S. S., Olson, S. D., Sears, C. M., & Cox, C. S. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1934447 · Cited by 46
Sun, Z., Zhao, H., Fang, D., Davis, C. T., Shi, D., Lei, K., Rich, B. E., Winter, J. M., Guo, L., Sorensen, L. K., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.07.015 · Cited by 47
Mechanisms coupling the hemostatic system to colitis-associated cancer
Palumbo, J. S., & Degen, J. L. (2010) · Thrombosis Research · doi:10.1016/s0049-3848(10)70011-6 · Cited by 44
Self-citationProthrombin and factor X are elevated in multiple sclerosis patients
Göbel, K., Kraft, P., Pankratz, S., Groß, C. C., Korsukewitz, C., Kwiecien, R., Mesters, R. M., Kehrel, B. E., Wiendl, H., Kleinschnitz, C., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24807 · Cited by 43
Vidal, B., Ardite, E., Suelves, M., Ruiz-Bonilla, V., Janué, A., Flick, M. J., Degen, J. L., Serrano, A. L., & Muñoz-Cánoves, P. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds012 · Cited by 39
Self-citationThrombin Drives Tumorigenesis in Colitis-Associated Colon Cancer
Turpin, B. K., Miller, W., Rosenfeldt, L. A., Kombrinck, K. W., Flick, M. J., Steinbrecher, K. A., Harmel-Laws, E., Mullins, E. S., Shaw, M. A., Witte, D. P., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3276 · Cited by 41
Self-citationLi, F., Gallego, J., Tirko, N. N., Greaser, J., Bashe, D., Patel, R., Shaker, E., Valkenburg, G. E. V., Alsubhi, A. S., Wellman, S. M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49709-9 · Cited by 43
Fibrin deposition following bile duct injury limits fibrosis through an αMβ2-dependent mechanism
Joshi, N., Kopec, A. K., Ray, J. L., Cline-Fedewa, H. M., Nawabi, A. M., Schmitt, T. M., Nault, R., Zacharewski, T. R., Rockwell, C. E., Flick, M. J., et al. (2016) · Blood · doi:10.1182/blood-2015-09-670703 · Cited by 42
Self-citationBarkaway, A., Attwell, D., & Korte, N. (2022) · Neurophotonics · doi:10.1117/1.nph.9.3.031914 · Cited by 39
Boroujerdi, A., Welser-Alves, J. V., & Milner, R. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.09.009 · Cited by 39
Shaw, M. A., Gao, Z., McElhinney, K. E., Thornton, S., Flick, M. J., Lane, A., Degen, J. L., Ryu, J. K., Akassoglou, K., & Mullins, E. S. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2932-15.2017 · Cited by 38
Self-citationLi, X., Zhu, Z., Gao, S., Zhang, L., Cheng, X., Li, S., & Li, M. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.04.029 · Cited by 41
Potential roles of cell-derived microparticles in ischemic brain disease
Horstman, L. L., Jy, W., Bidot, C., Nordberg, M. L., Minagar, A., Alexander, J. S., Kelley, R. E., & Ahn, Y. S. (2009) · Neurological Research · doi:10.1179/016164109x12445505689526 · Cited by 38
East, E., Gveric, D. O., Baker, D., Pryce, G., LIJNEN, H. R., & Cuzner, M. L. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00889.x · Cited by 36
Hultman, K., Cortes‐Canteli, M., Bounoutas, A., Richards, A. T., Strickland, S., & Norris, E. H. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12553 · Cited by 36
Hussain, R. Z., Hayardeny, L., Cravens, P. D., Yarovinsky, F., Eagar, T. N., Arellano, B., Deason, K. L., Castro-Rojas, C. M., & Stüve, O. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.08.622 · Cited by 39
Driessen, T. M., Lee, J. S., & Lim, J. (2018) · eLife · doi:10.7554/elife.39981 · Cited by 37
Ryu, J. K., Sözmen, E. G., Dixit, K., Montaño, M., Matsui, Y., Liu, Y., Helmy, E. W., Deerinck, T. J., Yan, Z., Schuck, R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.12.464152 · Cited by 37
Self-citationCCR2 monocytes repair cerebrovascular damage caused by chronic social defeat stress
Lehmann, M. L., Samuels, J. D., Kigar, S. L., Poffenberger, C. N., Lotstein, M. L., & Herkenham, M. A. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.01.011 · Cited by 36
Serum proteomics in multiple sclerosis disease progression
Tremlett, H. L., Dai, D. L., Hollander, Z., Kapanen, A. I., Aziz, T., Wilson-McManus, J., Tebbutt, S. J., Borchers, C. H., Oger, J., & Freue, G. V. C. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.02.018 · Cited by 34
Plantone, D., Inglese, M., Salvetti, M., & Koudriavtseva, T. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2018.01175 · Cited by 36
In VivoImaging of CNS Injury and Disease
Akassoglou, K., Merlini, M., Rafalski, V. A., Real, R., Liang, L., Jin, Y., Dougherty, S. E., Paola, V. D., Linden, D. J., Misgeld, T., et al. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1826-17.2017 · Cited by 34
Self-citationConnor, D. E., Chaitanya, G. V., Chittiboina, P., McCarthy, P., Scott, L. K., Schrott, L. M., Minagar, A., Nanda, A., & Alexander, J. S. (2017) · Pathophysiology · doi:10.1016/j.pathophys.2017.04.003 · Cited by 33
Pankratz, S., Bittner, S., Kehrel, B. E., Langer, H. F., Kleinschnitz, C., Meuth, S. G., & Göbel, K. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101723 · Cited by 32
Kant, R., (PhD), S. K. H., Fernández, J., Griffin, J., & Milner, R. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00333 · Cited by 30
Sun, W., Miao, J., Song, Y., Wang, Y., Pan, C., Guo, L., Zhao, X., Lan, Y., Qiu, X., Zhu, S., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.10.011 · Cited by 31
Piers, T. M., Heales, S., & Pocock, J. M. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.10.007 · Cited by 31
Proteomic Analysis of Cerebrospinal Fluid in a Fulminant Case of Multiple Sclerosis
Füvesi, J., Hanrieder, J., Bencsik, K., Rajda, C., Kovács, S. K., Kaizer, L., Beniczky, S., Vécsei, L., & Bergquist, J. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13067676 · Cited by 34
A possible new role for Aβ in vascular and inflammatory dysfunction in Alzheimer's disease
Zamolodchikov, D., & Strickland, S. (2016) · Thrombosis Research · doi:10.1016/s0049-3848(16)30367-x · Cited by 33
Petersen, M. A., Tognatta, R., Meyer‐Franke, A., Bushong, E. A., Mendiola, A. S., Yan, Z., Muthusamy, A., Merlini, M., Meza-Acevedo, R., Cabriga, B., et al. (2021) · Brain · doi:10.1093/brain/awab106 · Cited by 30
Self-citationBistolfi, F. (2007) · The Neuroradiology Journal · doi:10.1177/197140090702000612 · Cited by 30
Restoring immune suppression in the multiple sclerosis brain
Koning, N., Uitdehaag, B. M. J., Huitinga, I., & Hoek, R. M. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.09.005 · Cited by 32
Hoffmann, A., Hofmann, F., Just, I., Lehnardt, S., Hanisch, U., Brück, W., Kettenmann, H., Ahnert‐Hilger, G., & Höltje, M. (2008) · Glia · doi:10.1002/glia.20687 · Cited by 36
Bedoui, Y., Neal, J. W., & Gasque, P. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9793-6 · Cited by 28
Borjini, N., Paouri, E., Tognatta, R., Akassoglou, K., & Davalos, D. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113046 · Cited by 23
Self-citationMhambi, S., Fisher, D. W., Tchokonte, M. B. T., & Dube, A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091479 · Cited by 29
Knopp, R. C., Banks, W. A., & Erickson, M. A. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102648 · Cited by 29
Bernardino, P. N., Luo, A., Andrew, P. M., Crowe, C. M., González, M. I., Gelli, A., & Lein, P. J. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001836 · Cited by 30
Elevated plasma fibrinogen levels in multiple sclerosis patients during relapse
Acuña, J. A. S., de la Cruz, M. H., Ros, A. L., Prasca, S., Ginés, M. L. M., & Frutos, C. D. D. A. (2017) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2017.09.033 · Cited by 27
Brain fibrinogen deposition plays a key role in MS pathophysiology – Yes
Davalos, D., Mahajan, K. R., & Trapp, B. D. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519852723 · Cited by 27
Genome-Wide Multiple Sclerosis Association Data and Coagulation
Starza, S. L., Ferraldeschi, M., Buscarinu, M. C., Romano, S., Fornasiero, A., Mechelli, R., Umeton, R., Ristori, G., & Salvetti, M. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00095 · Cited by 27
Prats-Soteras, X., Jurado, M. Á., Ottino‐González, J., García‐García, I., Segura, B., Caldú, X., Sánchez-Garre, C., Miró, N., Tor, C., Palacios, M. J. S., et al. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0582-y · Cited by 26
Erythrocytes in multiple sclerosis – forgotten contributors to the pathophysiology?
Groen, K., Maltby, V. E., Sanders, K. A., Scott, R. J., Tajouri, L., & Lechner‐Scott, J. (2016) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/2055217316649981 · Cited by 26
Yang, Y., Tian, S.-J., Wu, L., Huang, D., & Wei-ping, W. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-010-9637-2 · Cited by 26
Linking inflammation and coagulation: novel drug targets to treat organ ischemia
Jennewein, C., Paulus, P., & Zacharowski, K. D. (2011) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e3283489ac0 · Cited by 27
Fibrin-targeting immunotherapy for dementia
Kantor, A. B., Akassoglou, K., & Stavenhagen, J. B. (2023) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2023.105 · Cited by 24
Self-citationProcessing of Factor XII during Inflammatory Reactions
Jukema, B. N., de Maat, S., & Maas, C. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2016.00052 · Cited by 24
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Stolz, L., Derouiche, A., Devraj, K., Weber, F., Brunkhorst, R., & Foerch, C. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0926-2 · Cited by 25
Effect of a protein corona on the fibrinogen induced cellular oxidative stress of gold nanoparticles
Kuschnerus, I. C., Lau, M., Giri, K., Bedford, N. M., Biazik, J. M., Ruan, J., & Garcia‐Bennett, A. E. (2020) · Nanoscale · doi:10.1039/d0nr00371a · Cited by 23
Metadata
- Authors
- Adams, R. A., Bauer, J., Flick, M. J., Sikorski, S. L., Nuriel, T., Lassmann, H., Degen, J. L., & Akassoglou, K.
- Affiliations
- University of California San Diego (US)
- Medical University of Vienna (AT)
- University of Cincinnati (US)
- ORCID
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2007-03-05
- Volume
- 204
- Issue
- 3
- Pages
- 571-582
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2137908
- OpenAlex
- W2142424019
- Cited by
- 335
- References
- 72
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 19 · 2023: 22 · 2022: 16 · 2021: 27 · 2020: 21 · 2019: 16 · 2018: 21 · 2017: 16 · 2016: 19 · 2015: 18 · 2014: 15 · 2013: 17 · 2012: 18
- FWCI
- 11.33
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS052189, P30NS047101, R01NS051470)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Keywords
- fibrinogen, microglial activation, Mac-1, CD11b/CD18, multiple sclerosis, experimental autoimmune encephalomyelitis, inflammatory demyelination, Akt signaling, Rho GTPase signaling, blood-brain barrier disruption, neuroinflammation
- MeSH terms
- Amino Acid Sequence, Animals, Cells, Cultured, Female, Fibrin, Fibrinogen, Mice, Inbred C57BL, Molecular Sequence Data, Peptide Fragments, Macrophage-1 Antigen, Microglia, Multiple Sclerosis, Relapsing-Remitting, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.